Vaccinex, Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/53ad11a3-9533-4a55-9abe-71dad5b6d993/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $601.0k | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-054318 |
| FY 2023 | $570.0k | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-039700 |
| FY 2022 | $275.0k | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011354 |
| FY 2021 | $900.0k | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-012778 |
| FY 2020 | $625.0k | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-012778 |
| FY 2019 | $523.0k | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009251 |
| FY 2018 | $724.0k | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007458 |
| FY 2017 | $90.0k | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007458 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).